Chronic retinal detachment and giant retinal tears in 34 dogs: outcome comparison of no treatment, topical medical therapy, and retinal reattachment after vitrectomy.
The outcomes of dog's eyes with chronic (> 1 month) retinal detachment and giant retinal tears without therapy were compared with those treated with topical steroids and antiglaucoma medications, and with those that received a vitrectomy, retinal reattachment, endolaser therapy, and silicone oil tamponade. Fourteen of 16 eyes that did not receive therapy developed uveitis and secondary glaucoma, and were enucleated (4) or eviscerated (6); and 2 dogs were euthanized due to blindness and uveitis. Two eyes in 2 dogs remain without treatment, 1 and 3 years later. Fifteen of 19 eyes that received topical therapy developed nonresponsive uveitis and secondary glaucoma, and were enucleated (4) or eviscerated (9), 1 dog that was affected bilaterally was euthanized; and 3 eyes remain on topical anti-inflammatory therapy and the medication has been discontinued on 1 eye. Four of 6 eyes surgically reattached remain without clinical manifestations of uveitis and secondary glaucoma and 3 of these eyes have functional vision. Light microscopic observations completed on failed globes in the 3 groups were similar.
Grahn
Bruce H
BH
Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, 52 Campus Drive Saskatoon, Saskatchewan. bruce.grahn@usask.ca
Barnes
Laura D
LD
Breaux
Carrie B
CB
Sandmeyer
Lynne S
LS
D000287:Administration, Topical; D000818:Animals; D004283:Dog Diseases / Q000188:drug therapy* / Q000601:surgery*; D004285:Dogs; D015353:Eye Enucleation / Q000662:veterinary; D005260:Female; D005901:Glaucoma / Q000209:etiology / Q000662:veterinary; D008297:Male; D012163:Retinal Detachment / Q000188:drug therapy / Q000601:surgery / Q000662:veterinary*; D012167:Retinal Perforations / Q000188:drug therapy / Q000601:surgery / Q000662:veterinary*; D012189:Retrospective Studies; D012827:Silicone Oils / Q000627:therapeutic use; D013256:Steroids / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014605:Uveitis / Q000209:etiology / Q000662:veterinary; D014821:Vitrectomy / Q000379:methods / Q000662:veterinary*
D012827:Silicone Oils; D013256:Steroids